Pro Pharma Announces New Medical Specialty Rebates Program for Payers and Manufacturers

CHATSWORTH, Calif. - Sept. 25, 2018 - PRLog -- Pro Pharma Pharmaceutical Consultants, Inc., a pharmaceutical consulting organization which focuses on data analytical expertise, is pleased to announce our new Medical Specialty Rebates Program.

According to Dr. Craig Stern, President, "This program provides fully transparent identification, analysis, submission and collection of medical specialty utilization for payers and manufacturers".

Summary Analysis Outputs:
    > Provide an output Rebatable Drug File with filters for potential 340b Providers and supporting NDC codes for rebate review

    > Manage the preparation and submission for rebate collections and overall management of manufacturers for recovery of fees for every rebate receipt:
         - All data submitted to manufacturers is sterilized to remove individual identifiers of patients and physicians

According to Carol Stern, CEO, "This program supports the Contracts which are between Plans/Employers/Coalitions, and Manufacturers to ensure complete knowledge by all parties involved in the submissions and payments process in a fully transparent manner".

Call and/or email now to schedule your Live Demo and One-on-One Free 15-Minute Consultation to begin developing your Organization's Call to Action.

To learn more about our Medical Specialty Rebate Program visit: http://www.propharmaconsultants.com/msr.html

About PRO PHARMA

PRO PHARMA is a multi-service, woman owned, privately held consulting firm offering a vast portfolio of services to public and private entities including self-insured employers, Taft Hartley Trusts and unions, public employers, for-profit hospitals and integrated health networks, health care insurance companies, worker's compensation insurers, small-to-medium sized HMO's, and physician groups.

As a primary service to plan sponsors for achieving below trend results, PRO PHARMA provides an integrated program of administrative process improvements, clinical quality oversight, and provider/member education.

PRO PHARMA's Consulting services are grounded in the use of data and the communication of that information to define benefit trends, drivers and other analytical indicators.   PRO PHARMA markets Biotech Modeling™, Invoice Screening™, Quality Management Program™, and Treatment Calendar™. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.

For more information about PRO PHARMA, please visit http://www.propharmaconsultants.com.